Magnetic Resonance Spectrum Imaging of Endometrial Lesions: A Diagnostic Performance Comparative Study with Pathological Findings
- 1Department of Radiology, The Obstetrics and Gynecology Hospital, Fudan University, Shanghai, China
- 2Department of Gynecology, The Obstetrics and Gynecology Hospital, Fudan University, Shanghai, China
- 3Department of Radiology, Shanghai Pudong Hospital, Fudan University Affiliated Pudong Medical Center, Shanghai, China
Abstract
Objective: To evaluate the diagnostic value and significance of magnetic resonance spectroscopy (MRS) in endometrial pathology.
Methods: In this retrospective study, the 1H-MRS records of patients with suspected abnormal endometrial conditions were analyzed. Single-voxel spectra acquired from the largest region of the lesions were evaluated. The peak heights and areas under the curves (AUCs) for different metabolic peaks (total choline (tCho), creatine (Cr), lactate, lipid, N-acetylaspartate (NAA)) were recorded. The patients were classified into two groups: benign (hyperplasia or polyp) and malignant. Statistical differences in each peak between the two groups were analyzed individually.
Results: Tumor lesions showed higher tCho (p=0.006), Cr(p=0.007), and lipid peaks (p=0.042) than benign endometrial lesions, together with increased tCho/Cr (p=0.021) and tCho/NAA ratios (p=0.016). In endometrial cancer, higher tCho(AUC=0.64), lipid (AUC=0.618), and tCho/Cr (AUC=0.649) were associated with higher tumor grade. Lipid and tCho/NAA also demonstrated value for differentiating endometrioid from non-endometrioid subtypes, with AUCs of 0.761 and 0.756, respectively. Lactate and an NAA-like peak were detectable in a subset of endometrial lesions. Multivariable logistic regression revealed that the incorporation of the proton MRS tCho metric into a baseline clinico-radiological model (age, body mass index (BMI), cancer antigen 125 (CA125)) significantly enhanced diagnostic performance (AUC = 0.797).
Discussion: tCho- and lipid-related MRS metrics may aid non-invasive characterization of malignancy and tumor aggressiveness, supporting preoperative subtype assessment and risk stratification.
Conclusion: MRS reflects the basic metabolic characteristics of tissues and aids in determining the nature and invasiveness of endometrial lesions.
Related
- Diagnostic Accuracy of Preoperative Magnetic Resonance Imaging for Staging Endometrial Carcinoma: A Retrospective Single-Centre Study
- Magnetic Resonance Imaging in the Preoperative Assessment of Anal Fistula: Diagnostic Performance and Comparison of the St. James and Garg Classifications
- Diagnostic performance of chat generative pre-trained transformer in detecting silicone implant rupture on breast magnetic resonance imaging.
- Diagnostic Performance of Magnetic Resonance Elastography Versus Vibration‐Controlled Transient Elastography for Liver Fibrosis Staging in Steatotic Liver Disease
- Diagnostic performance of ultra-low-field neurological magnetic resonance imaging: a systematic review and meta-analysis
BibTeX
@article{xu2026magnetic,
title = {{Magnetic Resonance Spectrum Imaging of Endometrial Lesions: A Diagnostic Performance Comparative Study with Pathological Findings}},
author = {Zhuoting Xu and Minhua Shen and Yue Zhou and Shuang Zhou and Guofu Zhang and He Zhang},
journal = {Current Medical Imaging},
year = {2026},
month = jul,
doi = {10.2174/0115734056457836260704084554},
url = {https://doi.org/10.2174/0115734056457836260704084554},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Magnetic Resonance Spectrum Imaging of Endometrial Lesions: A Diagnostic Performance Comparative Study with Pathological Findings
AU - Zhuoting Xu
AU - Minhua Shen
AU - Yue Zhou
AU - Shuang Zhou
AU - Guofu Zhang
AU - He Zhang
PY - 2026
DA - 2026/07/14
JO - Current Medical Imaging
DO - 10.2174/0115734056457836260704084554
UR - https://doi.org/10.2174/0115734056457836260704084554
AB - Objective: To evaluate the diagnostic value and significance of magnetic resonance spectroscopy (MRS) in endometrial pathology. Methods: In this retrospective study, the 1H-MRS records of patients with suspected abnormal endometrial conditions were analyzed. Single-voxel spectra acquired from the largest region of the lesions were evaluated. The peak heights and areas under the curves (AUCs) for different metabolic peaks (total choline (tCho), creatine (Cr), lactate, lipid, N-acetylaspartate (NAA)) were recorded. The patients were classified into two groups: benign (hyperplasia or polyp) and malignant. Statistical differences in each peak between the two groups were analyzed individually. Results: Tumor lesions showed higher tCho (p=0.006), Cr(p=0.007), and lipid peaks (p=0.042) than benign endometrial lesions, together with increased tCho/Cr (p=0.021) and tCho/NAA ratios (p=0.016). In endometrial cancer, higher tCho(AUC=0.64), lipid (AUC=0.618), and tCho/Cr (AUC=0.649) were associated with higher tumor grade. Lipid and tCho/NAA also demonstrated value for differentiating endometrioid from non-endometrioid subtypes, with AUCs of 0.761 and 0.756, respectively. Lactate and an NAA-like peak were detectable in a subset of endometrial lesions. Multivariable logistic regression revealed that the incorporation of the proton MRS tCho metric into a baseline clinico-radiological model (age, body mass index (BMI), cancer antigen 125 (CA125)) significantly enhanced diagnostic performance (AUC = 0.797). Discussion: tCho- and lipid-related MRS metrics may aid non-invasive characterization of malignancy and tumor aggressiveness, supporting preoperative subtype assessment and risk stratification. Conclusion: MRS reflects the basic metabolic characteristics of tissues and aids in determining the nature and invasiveness of endometrial lesions.
SN - 1573-4056
ER -